BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28253728)

  • 1. Expression of DNA methylation-related proteins in metastatic breast cancer.
    Cha YJ; Jung WH; Koo JS
    Neoplasma; 2017; 64(3):412-420. PubMed ID: 28253728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of the epigenetic methylation-related protein DNMT1 by breast cancer molecular subtype and stromal histology.
    Shin E; Lee Y; Koo JS
    J Transl Med; 2016 Apr; 14():87. PubMed ID: 27071379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer.
    Jung YY; Kim HM; Koo JS
    PLoS One; 2015; 10(9):e0137204. PubMed ID: 26334757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Expression of Amine Oxidase Proteins in Breast Cancer.
    Sun WY; Choi J; Cha YJ; Koo JS
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29261141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Site-Based Expression of Pentose Phosphate Pathway-Related Proteins among Breast Cancer Metastases.
    Cha YJ; Jung WH; Koo JS
    Dis Markers; 2017; 2017():7062517. PubMed ID: 28260828
    [No Abstract]   [Full Text] [Related]  

  • 6. Site-specific expression of amine oxidases in breast cancer metastases.
    Cha YJ; Jung WH; Koo JS
    Tumour Biol; 2018 May; 40(5):1010428318776822. PubMed ID: 29775160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cancer-associated fibroblast related proteins in metastatic breast cancer: an immunohistochemical analysis.
    Kim HM; Jung WH; Koo JS
    J Transl Med; 2015 Jul; 13():222. PubMed ID: 26163388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p16 and pRB in invasive breast cancer.
    Shin E; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2015; 8(7):8209-17. PubMed ID: 26339389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of sarcosine metabolism-related proteins according to metastatic site in breast cancer.
    Cha YJ; Kim DH; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(11):7824-33. PubMed ID: 25550822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
    Ogba N; Manning NG; Bliesner BS; Ambler SK; Haughian JM; Pinto MP; Jedlicka P; Joensuu K; Heikkilä P; Horwitz KB
    Breast Cancer Res; 2014 Dec; 16(6):489. PubMed ID: 25475897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expressions of autotaxin-lysophosphatidate signaling-related proteins in metastatic breast cancer.
    Shim SJ; Shin E; Lee CS; Koo JS
    Int J Clin Exp Pathol; 2019; 12(8):2920-2930. PubMed ID: 31934128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
    Zhang HM; Zhang BN; Xuan LX; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of DNA methylation-related proteins in invasive lobular carcinoma of breast: comparison to invasive ductal carcinoma.
    Cha YJ; Kim HM; Koo JS
    Histol Histopathol; 2017 Nov; 32(11):1175-1185. PubMed ID: 28111737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distant metastasis in triple-negative breast cancer.
    Tseng LM; Hsu NC; Chen SC; Lu YS; Lin CH; Chang DY; Li H; Lin YC; Chang HK; Chao TC; Ouyang F; Hou MF
    Neoplasma; 2013; 60(3):290-4. PubMed ID: 23373998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of reactive oxygen species-related proteins in metastatic breast cancer is dependent on the metastatic site.
    Kim HM; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(12):8802-12. PubMed ID: 25674249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients.
    Kalinsky K; Mayer JA; Xu X; Pham T; Wong KL; Villarin E; Pircher TJ; Brown M; Maurer MA; Bischoff FZ
    Clin Transl Oncol; 2015 Jul; 17(7):539-46. PubMed ID: 25613123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Yes-associated protein (YAP) in metastatic breast cancer.
    Kim HM; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2015; 8(9):11248-57. PubMed ID: 26617849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis.
    Loehberg CR; Almstedt K; Jud SM; Haeberle L; Fasching PA; Hack CC; Lux MP; Thiel FC; Schrauder MG; Brunner M; Bayer CM; Hein A; Heusinger K; Heimrich J; Bani MR; Renner SP; Hartmann A; Beckmann MW; Wachter DL
    Breast Cancer Res Treat; 2013 Apr; 138(3):899-908. PubMed ID: 23479421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.
    Thangarajah F; Vogel C; Pahmeyer C; Eichler C; Holtschmidt J; Ratiu D; Mallmann P; Malter W
    Anticancer Res; 2018 Oct; 38(10):6023-6026. PubMed ID: 30275235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
    Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.